Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable polyketide synthase Pks5 | 0.0133 | 0.4144 | 0.5551 |
Mycobacterium tuberculosis | Probable membrane bound polyketide synthase Pks6 | 0.0205 | 0.7465 | 1 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSE | 0.0091 | 0.2195 | 0.2941 |
Loa Loa (eye worm) | AMP-binding enzyme family protein | 0.0128 | 0.3922 | 0.3889 |
Mycobacterium leprae | Probable multifunctional mycocerosic acid synthase membrane associated enzyme Mas | 0.0145 | 0.473 | 0.6337 |
Treponema pallidum | amino acid ABC transporter, periplasmic binding protein | 0.0057 | 0.0649 | 0.5 |
Mycobacterium tuberculosis | Polyketide synthase Pks12 | 0.0145 | 0.473 | 0.6337 |
Mycobacterium leprae | Polyketide synthase Pks13 | 0.0205 | 0.7465 | 1 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0137 | 0.4337 | 0.581 |
Loa Loa (eye worm) | fatty acid synthase | 0.0135 | 0.4253 | 0.4318 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0145 | 0.473 | 1 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSD | 0.0137 | 0.4337 | 0.581 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSC | 0.0145 | 0.473 | 0.6337 |
Mycobacterium tuberculosis | Polyketide synthase Pks2 | 0.0133 | 0.4144 | 0.5551 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSA | 0.0137 | 0.4337 | 0.581 |
Treponema pallidum | amino acid ABC transporter, periplasmic binding protein (hisJ) | 0.0057 | 0.0649 | 0.5 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0137 | 0.4337 | 0.581 |
Onchocerca volvulus | Fatty acid synthase homolog | 0.0247 | 0.9413 | 1 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSB | 0.011 | 0.3102 | 0.4155 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks9 | 0.0078 | 0.1609 | 0.2155 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 3 | 0.0079 | 0.1677 | 0.5 |
Toxoplasma gondii | beta-ketoacyl synthase, N-terminal domain-containing protein | 0.0089 | 0.2116 | 0.2574 |
Mycobacterium ulcerans | glutamine-binding lipoprotein GlnH | 0.0057 | 0.0649 | 0.0869 |
Mycobacterium ulcerans | thioesterase | 0.0114 | 0.3283 | 0.4398 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsB | 0.011 | 0.3102 | 0.4155 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0137 | 0.4337 | 0.581 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks1 | 0.0098 | 0.2556 | 0.3424 |
Mycobacterium tuberculosis | Polyketide synthase Pks13 | 0.0205 | 0.7465 | 1 |
Echinococcus granulosus | nmda type glutamate receptor | 0.0079 | 0.1677 | 0.5 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsE | 0.0091 | 0.2195 | 0.2941 |
Mycobacterium tuberculosis | Probable thioesterase TesA | 0.0114 | 0.3283 | 0.4398 |
Mycobacterium ulcerans | thioesterase TesA | 0.0114 | 0.3283 | 0.4398 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.011 | 0.3102 | 0.4155 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0145 | 0.473 | 0.6337 |
Echinococcus multilocularis | nmda type glutamate receptor | 0.0079 | 0.1677 | 0.5 |
Mycobacterium ulcerans | multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0145 | 0.473 | 0.6337 |
Mycobacterium leprae | Probable polyketide synthase Pks1 | 0.0145 | 0.473 | 0.6337 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0137 | 0.4337 | 0.581 |
Mycobacterium ulcerans | polyketide synthase Pks9 | 0.0091 | 0.2195 | 0.2941 |
Mycobacterium ulcerans | polyketide synthase Pks13 | 0.0205 | 0.7465 | 1 |
Mycobacterium tuberculosis | Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) | 0.0128 | 0.3922 | 0.5254 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks7 | 0.0145 | 0.473 | 0.6337 |
Mycobacterium ulcerans | polyketide synthase | 0.0137 | 0.4337 | 0.581 |
Mycobacterium tuberculosis | Probable glutamine-binding lipoprotein GlnH (GLNBP) | 0.0057 | 0.0649 | 0.0869 |
Chlamydia trachomatis | arginine ABC transporter substrate-binding protein ArtJ | 0.0057 | 0.0649 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.023 | 0.8637 | 1 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0137 | 0.4337 | 0.581 |
Mycobacterium ulcerans | polyketide synthase | 0.0145 | 0.473 | 0.6337 |
Loa Loa (eye worm) | hypothetical protein | 0.0077 | 0.1557 | 0.0823 |
Chlamydia trachomatis | glutamine binding protein | 0.0057 | 0.0649 | 0.5 |
Onchocerca volvulus | 0.0238 | 0.9021 | 0.9285 | |
Mycobacterium tuberculosis | Polyketide synthetase MbtC (polyketide synthase) | 0.0047 | 0.0188 | 0.0251 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0097 | 0.2515 | 0.3708 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks8 | 0.0112 | 0.3185 | 0.4267 |
Mycobacterium tuberculosis | Probable multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0145 | 0.473 | 0.6337 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks15 | 0.0055 | 0.0571 | 0.0765 |
Brugia malayi | Beta-ketoacyl synthase, N-terminal domain containing protein | 0.0137 | 0.4337 | 0.0684 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0137 | 0.4337 | 0.581 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0137 | 0.4337 | 0.581 |
Mycobacterium leprae | PROBABLE THIOESTERASE TESA | 0.0114 | 0.3283 | 0.4398 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | 0 | Activity at ERalpha in human HEC1 cells assessed as antagonism of estradiol-activated transcription activation relative to estradiol | ChEMBL. | 16279785 |
Activity (functional) | 0 | Activity at ERbeta in human HEC1 cells assessed as antagonism of estradiol-activated transcription activation relative to estradiol | ChEMBL. | 16279785 |
Ratio (binding) | = 11 | Ratio of RBA for human estrogen receptor alpha to RBA for human estrogen receptor beta | ChEMBL. | 16279785 |
RBA (binding) | = 0.059 % | Displacement of [3H]estradiol from human ERbeta relative to estradiol | ChEMBL. | 16279785 |
RBA (binding) | = 0.059 % | Displacement of [3H]estradiol from human ERbeta relative to estradiol | ChEMBL. | 16279785 |
RBA (binding) | = 0.64 % | Displacement of [3H]estradiol from human ERalpha relative to estradiol | ChEMBL. | 16279785 |
RBA (binding) | = 0.64 % | Displacement of [3H]estradiol from human ERalpha relative to estradiol | ChEMBL. | 16279785 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.